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Abstract Aims/hypothesis: The heritability of fasting
glucose levels in Northern European populations has been
examined previously in twins and samples of small
pedigrees. In this study the heritability of fasting plasma
glucose (FPG) was estimated in participants in the Erasmus
Rucphen Family study, who were members of a single
pedigree from a young genetic isolate. We also studied the
relationship between FPG and components of the metabolic
syndrome. Methods: FPG, lipid, blood pressure and body
composition measurements were completed for 852
participants without diabetic medication. The most signif-
icant predictors of FPG were used as covariates in
heritability estimation. The sibship effect, which is a
composite of genetic dominance and shared early-life
environmental effects, was included as a random effect.
Results: The age- and sex-adjusted heritability of log
normal-transformed FPG was 36.6%. When further
adjusted for metabolic risk factors, namely body composi-
tion parameters, systolic blood pressure, triglycerides and
cholesterol:HDL ratio, the heritability estimate rose to
42.8%. After adjustment for the sibship effect, the additive
component of heritability was estimated to be 28.3% (age-
and sex-adjusted) and 24.9% (full model). Conclusions/
interpretation: Genes control a significant proportion of
the variance in FPG levels. Adjustment for other metabolic
risk factors did not substantially change the heritability
estimate, which suggests that a large part of the variance in
FPG levels is due to genes that act through pathways that
are independent of those controlling body composition,
blood pressure and lipid levels.
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SBP: systolic blood pressure . Trig: triglycerides .
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Introduction
The prevalence of diabetes mellitus is rising rapidly
worldwide. In 1995, 135 million adults were affected
with diabetes globally, and this number is estimated to reach
300 million by 2025 [1]. An elevated fasting glucose level
is the most commonly used method of diagnosing diabetes.
Other indices, such as abdominal obesity, hypertension,
hyperlipidaemia and hypertriglyceridaemia, are also asso-
ciated with elevated fasting glucose. These phenotypes tend
to cluster together as the metabolic syndrome [2]. The
prevailing hypothesis is that the different metabolic
syndrome components are, at least in part, caused by
common genes [3]. However, these metabolic states are
also greatly influenced by environmental factors, such as
intrauterine environment, diet and physical activity [4, 5].
As an initial step in the search for genes that cause
altered metabolic states, heritability studies have been
conducted for various traits, particularly for diabetes and its
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endophenotypes. The heritability estimate shows how
much of the phenotypic variance is attributable to the
average effects of genes [6]. For fasting glucose, heritabil-
ity studies in Northern Europe have mostly been done
using twin registers, in which heritability estimates ranged
from 38 to 51% [7–9]. Heritability estimates tend to be
higher among twins than in extended pedigrees because of
greater similarities in early-life environment and behav-
ioural patterns among twins. In family studies, heritability
estimates vary widely (8–72%), which may be partly due to
ascertainment bias [10, 11]. In a study of 89 randomly
ascertained pedigrees, in which variance due to childhood
household was also measured, the heritability of fasting
glucose was 18% after adjustment for age, sex, BMI, and
smoking [12].
Here we report the heritability of fasting plasma
glucose (FPG) in a large extended pedigree with 6,592
members, among whom 951 living subjects were char-
acterised for different metabolic parameters. Ascertain-
ment of the sample was based not on disease status, but
on the participants’ relation to 20 couples who lived in
the area in the second half of the nineteenth century. The
presence of numerous extended relative pairs allowed the
distinction between additive genetic and sibship effects,
the latter being a composite of genetic dominance and
shared early-life environment effects. Phenotypic de-
scription of this population includes a serum lipid profile
and fat and lean mass measurements using dual-energy
X-ray absorptiometry (DEXA), thus enabling us to study
the relation between FPG and a number of metabolic
syndrome features, such as obesity, hypertension and
hypertriglyceridaemia.
Subjects and methods
Study sample
Our study sample was based on a young, genetically
isolated population in the southwest of The Netherlands.
This community was founded by ∼150 Caucasians in the
mid-eighteenth century. Since then there has been minimal
migration from the community and few marriages with
people from outside the community. Today roughly 20,000
people live within the community and its neighbouring
areas. For this population, an extensive genealogical
database is available, which was reconstructed through
detailed church and municipal records.
The study protocol was approved by the medical ethics
board of Erasmus MC Rotterdam. All investigations were
carried out in accordance with the Declaration of Helsinki.
The Erasmus Rucphen Family (ERF) study was designed to
sample approximately 3,000 people who are descendants of
20 couples from the second half of the nineteenth century.
Thus, the sample was ascertained on the basis of kinship
and not on disease status. The 20 founding couples were
related to each other through previous generations; hence
study participants are members of a single large extended
pedigree. Analysis of this highly complex pedigree struc-
ture by PEDSTATS [13] revealed 1,444 founders and 5,148
non-founders, with 1,617 consanguineous marriages and
3,060 sibships (average size of the sibships is 2). The
number of each type of relative pair is reported in Table 1.
The mean of the inbreeding coefficient is 0.003±0.00008
(range 0–0.066), which indicates that most of the consan-
guineous marriages are between relations of at least the fifth
degree.
Members of the pedigree were invited to our research
centre, which is located in the vicinity. Participants were
sent questionnaires and consent forms prior to arrival at the
centre and interviewed upon arrival, thus ensuring
informed consent. During a one-day visit, each participant
underwent several examination blocks that included a
medical history obtained by a physician, venipuncture for
biochemistry, and blood pressure and anthropometric
measurements, including those by DEXA.
Assessment of study variables
Participants were asked to bring all current medications for
registration. This information was used to create variables
for antidiabetic (insulin and oral hypoglycaemic) treatment,
as well as antihypertensive, lipid-lowering and potentially
glucose-increasing agents (i.e. oral glucocorticoids, thyroid
hormone, β-agonists, thiazides and β-blockers).
Participants were asked to fast for at least 8 h prior to
blood withdrawal. Blood samples were then sent to the
local laboratory for standard plasma glucose and serum
lipid measurements, which were made using a Synchron
LX 20 Systems analyser (Beckman Coulter, Fullerton, CA,
USA).
Blood pressure in the right arm was measured while
sitting, using an automated device (OMRON HEM-711;
OMRON Healthcare, Vernon Hills, IL, USA) after at least
5 min of rest. The average of two measurements taken
5 min apart was used for analysis. Pulse pressure and mean
Table 1 Number of relative pairs within pedigree from the ERF
study
Characteristic Whole pedigree (n) Phenotyped subset (n)
Pedigree members 6,592 852a
Founders 1,444 140
Non-founders 5,148 712
Relative pairs
Parent–offspring 10,296 326
Sibling–sibling 3,876 468
Grandparent 16,298 26
Avuncular 14,902 785
Half-siblings 449 22
Cousins 17,364 1,998
Number of relative pairs given in the third column denotes the
number of pairs for which quantitative phenotypes are available for
both members of the pair
aAlthough only 852 were phenotyped, the structure of the whole
pedigree including 6,592 individuals was used as input for
heritability analyses
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arterial pressure were calculated as possible surrogate
measures.
Anthropometric and DEXA measurements were made
with participants in their underwear and without shoes.
Using soft tape, with the subject in the standing position,
waist circumference was measured midway between the
lower costal margin and the iliac crest, while hip circum-
ference was taken at the hip’s widest diameter. Waist-to-hip
ratio (WHR) was then computed. Height and weight were
also measured. BMI was calculated as weight in kilograms
divided by the square of height in metres. All DEXA scans
were performed in a calibrated Prodigy total body fan-
beam densitometer and analysed with enCORE 2002
software version 6.70.021 (GE Lunar, Madison, WI, USA).
Other parameters estimated by DEXA included fat and lean
mass for total body, trunk and legs. The following
indices were then determined: %fat mass FMð Þ ¼ FM
FMþ lean massÞð , both for total body and for body
regions; lean mass index (LMI) = total lean mass (in kg)/
(height in m)2; fat mass index (FMI) = total FM (in kg)/
(height in m)2; total/trunk fat ratio; total/legs fat ratio;
and trunk/legs fat ratio (Tr/l).
Of 951 phenotyped participants (as of September 2003),
905 had FPGmeasurements, 47 of whom were identified as
using antidiabetic medications. Inclusion of participants
who were on antidiabetic treatment resulted in a severely
skewed distribution for both FPG and triglyceride (Trig)
variables. Therefore, analysis was restricted to 852
participants without antidiabetic treatment, who also had
complete measurements on body composition, lipids and
blood pressure.
Statistical analysis
SPSS 11.0.1 (SPSS, Chicago, IL, USA) was used for
descriptive and regression analyses. The large number of
measurements and participants permitted adjustment for
multiple covariates in the analyses. Apart from lipid, body
and blood pressure measurements, information on smoking
and medications that may potentially increase glucose
levels were available. Because of its non-linear relationship
with glucose, age was categorised into five groups with 15-
year intervals. Because the distribution of FPG was not
normal, log normal (ln)-transformed FPG was regressed on
each covariate. Multiple regression analysis was then
performed with all the covariates in the model. Covariates
were also grouped into blocks, i.e. body composition,
blood pressure and lipids. For each block the most
significant independent predictors were chosen on the
basis of existing literature and on multivariable regression
analyses done for each block separately and with all blocks
together. By hierarchical modelling and multiple linear
regression with different covariate subsets, the following
covariates were identified as significant: lnFPG ∼μ+βage
age+βLMI LMI+βFMI FMI+βTr/l Tr/l+βSBP systolic blood
pressure (SBP)+βTrig Trig+βTC/HDL total cholesterol/
HDL-cholesterol ratio (TC/HDL). Sex was kept as a
covariate in the final model. Potentially glucose-increasing
medication and smoking did not affect FPG significantly
and were therefore excluded from further analyses.
In heritability analysis, we assumed a standard model
describing the expectation of the quantitative trait, Qij, of
the ith person who is an offspring of the jth mother as
Qij ¼ μþ
X
k
βk Cki þ ai þ sj þ "ij;
where μ is the population mean, Cki is the value of kth
covariate (fixed effect) for person i, βk is the regression
coefficient, ai is the additive genetic effect, sj is the sibship
effect (which is discussed below) and ɛij is the residual
(environmental) effect. It is assumed that random additive
genetic, sibship and environmental effects are normally
distributed with mean zero and variances equal to σ2a;σ
2
s
and σ2e; respectively. The variance–covariance structure is
given by
Cov i; jð Þ ¼ σ
2
a þ σ2s þ σ2e; if i ¼ j
2φijσ
2
a þ ηijσ2s ; if i 6¼ j

;
where φij is the coefficient of kinship between individuals i
and j, and ηij is equal to one if i and j share the same mother
(and are therefore sibs or maternal half-sibs). In the above
formulation, the narrow-sense heritability is defined as h2 ¼
σ2a

σ2a þ σ2e
 
when the sibship effect is not considered,
and by h2 ¼ σ2a

σ2a þ σ2s þ σ2e
 
when the sibship effect is
included in the analysis. The proportion of variance due to
the sibship effect was computed with the formula S ¼ σ2s

σ2a þ σ2s þ σ2e
 
.
The sibship effect estimates phenotypic similarities
induced in the progeny of the same mother. This effect is
a combination of effects induced by shared early-life
environment and dominance genetic effects. It may be
argued that this effect is better termed ‘maternal’. However,
one widely accepted definition of the maternal effect is a
mitochondrial effect, which we did not directly estimate in
our model. Moreover, because of the small number of half-
sibs in our sample (Table 1) and the non-delineation of
household effects in our data set, the effect due to sharing
the same mother is almost indistinguishable from the
sibship effect. Therefore, for clarity we refer to it as the
‘sibship effect’.
To estimate the linear mixed model described above, the
ASReml 1.10 program (NSW Agriculture Biometrics,
NSW, Australia; URL http://www.vsn-intl.com/ASReml/)
for restricted maximum likelihood analysis was used.
ASReml calculates the inverse relationship matrix from
the pedigree structure. In this study the entire pedigree
including 6,592 members was analysed as a single unit;
each analysis took only a few minutes to run since the
software was developed for analysis of agricultural data
and is capable of handling extremely large experimental
data sets. Because the ASReml manual recommends that
all covariates have a normal distribution, values of LMI,
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FMI, Tr/l, SBP, Trig and TC/HDL were ln-transformed to
improve normality. ASReml was used to fit a linear mixed
model to the data, with the covariate traits as fixed effects
and the genetic and sibship effects as random effects.
The statistical significance of random effects (heritability
and sibship effect) was assessed using the likelihood ratio
test. Under the null hypothesis, twice the difference
between the residual log likelihood values from the nesting
models with the same fixed effects follows a χ2 distribu-
tion, with the number of degrees of freedom equal to the
difference in the number of estimated parameters. Due to
the nature of restricted maximum likelihood, the likelihood
ratio test cannot be used to assess the significance of fixed
effects. However, the square of the ratio between the
estimate and the standard error, which follows a χ2
distribution, can be used for testing. All heritabilities are
reported as the estimate h2±SE.
Results
At the time of analysis, measurements of FPG, body
composition, blood pressure and lipids were complete for
852 individuals (Table 1). The mean age of participants was
51.9±14.0 years SD (median 52.4, range 18–85). Table 2
shows the characteristics of the study population. Blood pres-
sure and lipid measurements, except for HDL cholesterol,
were significantly different among age groups (data not
shown). Males constituted 40% of the sample. Sex-related
differences were found for FPG, age, BMI, WHR, total fat
mass, LMI, FMI, fat mass ratios, HDL cholesterol, Trig, TC/
HDL and blood pressure (not all data shown). To account for
these sex differences, sex was maintained as a covariate in the
models for heritability estimation, even though sex was not
significant in multiple regression analyses with all covariates
included and with the covariates grouped into blocks.
The heritability estimate for FPG was 36.6±8.6% in the
sample of participants without antidiabetic medications,
when adjusted for age and sex (Table 3). To study the
relationship between metabolic risk factors and FPG,
adjustment for these factors was made and the correspond-
ing changes in heritability estimates were noted. Adjust-
ment for body composition parameters (LMI, FMI and Tr/l)
increased the heritability of FPG (43.2±8.9%). In contrast,
adding SBP or Trig and TC/HDL to the model produced a
slight reduction in heritability. Using the full model, which
includes variables that represent each component of the
metabolic syndrome, we obtained a heritability estimate of
42.8±9.0%.
Excluding patients with antidiabetic treatment elimi-
nated more extreme glucose levels. When subjects with
antidiabetic medication were included in the analysis
(n=905), the heritability estimate did not change substan-
tially after correction for treatment, using all models. For
this analysis, the categorical variable for antidiabetic
treatment was a significant covariate.
It has been suggested previously that early-life environ-
ment may contribute to the homeostatic control of blood
glucose levels in adulthood [14]. Therefore, the sibship
effect was included in the model as a random effect.
Inclusion of the sibship effect reduced heritability estimates
for all models, the age- and sex-adjusted and fully adjusted
estimates being 28.3±10.6 and 24.9±11.6%, respectively
(Table 3). Despite the fact that heritability estimates were
lower, they remained significant at p<0.05 for all models.
In models with the sibship effect, the regression
coefficients for covariates were virtually the same as in
the initial analysis not including sibship effect (data not
shown). Age was a significant covariate in all the models
tested, with or without the sibship effect (p<0.05).
Likelihood ratio testing showed that addition of the sibship
effect to the model was statistically significant only when
body composition covariates were added into the model:
sibship effect p values were significant only for model 2
(p<0.01, age, sex and body composition as covariates) and
model 5 (p<0.01, full model) in Table 3. Interestingly, for
Table 2 Clinical characteristics of 852 participants in the ERF study
Traita Overall By sex
Mean±SE ln Mean±SEb Skewnessc Kurtosisc Men Women p value
n 852 – – – 345 507 –
Age (years) 51.9±0.48 3.9±0.01 −0.2 −0.6 53.5±0.73 50.8±0.49 0.006
FPG (mmol/l) 4.6±0.03 1.5±0.006 1.3 4.1 4.8±0.04 4.5±0.03 <0.001
LMI (kg/m2) 16.9±0.09 2.8±0.005 0.4 −0.4 19.1±0.10 15.4±0.06 <0.001
FMI (kg/m2) 9.0±0.12 2.1±0.02 0.5 0.4 7.4±0.15 10.1±0.12 <0.001
Tr/l 2.0±0.02 0.6±0.01 0.8 0.4 2.6±0.03 1.6±0.02 <0.001
SBP (mmHg) 141.0±0.75 4.9±0.005 0.9 1.0 145.2±1.10 138.1±0.77 <0.001
Trig (mmol/l) 1.4±0.03 0.2±0.02 2.0 7.4 1.6±0.05 1.2±0.02 <0.001
TC/HDL 4.7±0.05 1.5±0.01 0.5 0.1 5.1±0.08 4.3±0.04 <0.001
The following variables were the most significant predictors after multiple regression analyses: age, LMI, FMI, Tr/l, SBP, Trig and TC/HDL
aFPG fasting plasma glucose; LMI lean mass index; FMI fat mass index; Tr/l trunk/legs fat ratio; SBP systolic blood pressure; Trig
triglycerides; TC/HDL ratio total cholesterol/HDL
bln Mean average of ln-transformed values
cSkewness and kurtosis reported are for the distribution of original non-transformed values
dp value by t test using ln-transformed values
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the same models with body composition parameters, the
effect of sex was non-significant. LMI, FMI, SBP and Trig,
but not Tr/l and TC/HDL, reached statistical significance
when included in the analysis.
Discussion
Despite many studies on the genetics of the metabolic
syndrome and its components, the relative roles of
environment and genetics in this syndrome remain unclear.
In our study, adjustment for metabolic risk factors
increased rather than decreased heritability estimates of
FPG. This may mean that a significant portion of the
variance in glucose levels is due to genes that act through
pathways that are independent of those controlling body
composition, blood pressure and lipid levels.
After adjustment for age, sex, metabolic risk factors and
the sibship effect, the heritability of FPG in this sample was
25%. The sibship effect was significant in models that
included body composition measurements as covariates
(model 2 and the full model model 5). In these models, the
sibship effect explained an amount of variability in glucose
levels that was similar to that explained by the additive
genetic component. Modelling of the sibship effect in the
absence of genetic marker data does not allow distinction
between the contributions of shared early-life environment
and dominance genetic effects. These environmental
effects, which may contribute to the shared environment
of siblings, are likely to be mediated by maternal influences
(e.g. intrauterine environment and neonatal feeding) and
lifestyle effects (e.g. diet and physical activity).
The intrauterine environment has been shown to affect
adult glucose metabolism. In human studies of middle-
aged subjects whose mothers were exposed to famine
during pregnancy, significant glucose intolerance was
noted [14]. In rat studies, adults with fetal protein
malnutrition had decreased insulin release but normal
peripheral uptake in muscle [15]. This supports the
hypothesis that impaired development of beta cell function
due to early-life food deprivation predisposes to impaired
glucose tolerance in adulthood, particularly after later
adaptation of sedentary and/or hyperphagic lifestyles [16].
Glucose levels increased significantly with age, as
shown by the age coefficients in our analysis (Table 3).
However, the progressive increase in glucose levels with
age stopped at the age range 50–75; those aged ≥75 had
lower glucose levels (Table 3). This may be due to a
healthy survivor effect, such that those who survived
beyond age 75 may constitute a special population that is
characterised by a specific blend of genetic and environ-
mental factors which contribute to longevity. Though sex
Table 3 Heritability of ln-transformed fasting glucose (h2lnFPG±SE)
Parametera Modelb
1 2 3 4 5
Without sibship effect
μ 1.42±0.02 0.62±0.15 0.54±0.19 1.42±0.02 0.07±0.23
βage30–45 0.06±0.02 0.04±0.02 0.06±0.02 0.06±0.02 0.04±0.02
βage45–60 0.14±0.02 0.09±0.02 0.12±0.02 0.12±0.02 0.08±0.02
βage60–75 0.19±0.02 0.14±0.02 0.16±0.02 0.18±0.02 0.12±0.02
βage75+ 0.13±0.03 0.10±0.03 0.09±0.03 0.12±0.03 0.07±0.03
βsex −0.05±0.01 −0.009±0.02 −0.05±0.01 −0.04±0.01 −0.008±0.02
βlnLMI [0] 0.23±0.05 [0] [0] 0.24±0.05
βlnFMI [0] 0.07±0.01 [0] [0] 0.06±0.01
βlnTr/l [0] 0.03±0.02 [0] [0] 0.02±0.02
βlnSBP [0] [0] 0.18±0.04 [0] 0.11±0.04
βlnTrig [0] [0] [0] 0.04±0.01 0.02±0.01
βlnTC/HDL [0] [0] [0] −0.009±0.02 0.03±0.02
h2lnFPG (%) 36.6±8.6 43.2±8.9 35.6±8.7 37.7±8.8 42.8±9.0
2e 0.014 0.012 0.014 0.013 0.011
p value, h2lnFPG
c 4×10−6 1×10−6 1×10−5 6×10−6 1×10−6
With sibship effect
h2lnFPG (%) 28.3±10.6 26.4±11.4 26.1±10.7 28.5±10.8 24.9±11.6
%S (sibship effect) 12.3±7.0 22.3±7.3 13.4±7.1 13.7±7.2 22.8±7.4
2e 0.013 0.010 0.013 0.013 0.011
p value, Sc 0.08 0.001 0.06 0.06 0.001
aμ Intercept; LMI lean mass index; FMI fat mass index; Tr/l trunk/legs fat ratio; SBP systolic blood pressure; Trig triglyceride; TC/HDL ratio
total cholesterol/HDL; 2e environmental variance. Age group 15–30 is reference categorybStatistical models: 1, lnFPG ∼age+sex; 2, lnFPG ∼age+sex+lnLMI+lnFMI +lnTr/l; 3, lnFPG ∼age+sex+lnSBP; 4, lnFPG ∼age+sex+
lnTrig+lnTC/HDL; 5, lnFPG ∼age+sex+lnLMI+lnFMI+lnTr/l+lnSBP+lnTrig+lnTC/HDL (full model). [0] Coefficient set to zero/variable
not included in model
cp values were derived using the likelihood ratio test
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affects variability in glucose levels, sex differences became
non-significant after adjustment for body composition.
Unexpectedly, among the body composition parameters,
LMI had the highest impact, both in terms of significance
and the effect size on FPG. Several studies have demon-
strated that visceral or abdominal obesity and high fat
mass, more than BMI, are associated with insulin resistance
[17]. The strong positive association between LMI and
FPG deserves further investigation.
Genetically isolated populations are characterised by
inbreeding and increased genetic drift and thus may deviate
in their genetic composition from the general population.
Moreover, in such populations there is an increased chance
of loss or fixation of some genetic variants, thus potentially
leading to lower genetic diversity and consequently lower
heritability. However, in a recent study [18] we have shown
that effects of drift are relatively small in our genetically
isolated population and the chance of losing an allele is
very small, unless it had a very low frequency in the
original population. Thus, our population should not
deviate much from the general population in its genetic
composition and we do not expect that our heritability
estimates would differ substantially from those in the
general Dutch population.
Recent studies on fasting glucose among populations of
European descent have found linkage to different chromo-
somes. In the Finnish population, where the heritability of
fasting glucose was estimated to be 8.4% after correction
for ascertainment, elevated fasting glucose was sugges-
tively linked to chromosome 3 [19]. In another population
of European Caucasian descent, the heritability of fasting
glucose was 34%, but only suggestive linkage to chromo-
some 10q and weak linkage to 1q were found [20]. Given a
heritability estimate of at least 25% for FPG, further
linkage studies in the ERF population could well find genes
that affect FPG levels and possibly play a role in outbred
populations.
In conclusion, the heritability of FPG in this young,
genetically isolated population is at least 25%. Sibship
variance, which includes dominance genetic effects and
common effects of the early-life environment, contributed
a similar amount of variability in glucose levels after
adjustment for body composition. A significant proportion
of the variance in FPG level is controlled by genes that act
independently of genes that influence body composition,
blood pressure and lipids.
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